Literature DB >> 12879481

Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.

Seyed F A Amlashi1, Laurent Riffaud, Gilles Brassier, Xavier Morandi.   

Abstract

BACKGROUND: Patients with nevoid basal cell carcinoma syndrome (NBCCS) are believed to be predisposed to develop early-onset neoplasms including medulloblastomas (MB). The desmoplastic subtype of MB is associated most commonly with NBCCS. The goals of this study were to demonstrate the relation between desmoplastic MB and NBCCS and to evaluate the concomitant diagnosis of NBCCS and MB.
METHODS: The medical records of 76 consecutive children who received surgical treatment for MB between 1970 and 2000 were studied. A review of the literature was performed based on the National Library of Medicine database and bibliographies of selected articles were scanned.
RESULTS: The authors reported three patients with NBCCS who received surgical treatment for an MB during infancy. The literature review identified 33 patients with NBCCS who were treated for MB at a mean age of 28 months. The desmoplastic subtype was the only histopathologic subtype of MB reported in the NBCCS population. Although patients with NBCCS are predisposed to develop multiple basal cell carcinomas and intracranial tumors in the field of irradiation, the prognosis for syndromic MBs was much better compared with the prognosis for sporadic MBs.
CONCLUSIONS: Patients with NBCCS have an increased risk for other malignancies, especially radiation-induced neoplasms. Early diagnosis of this syndrome is important for the selection of appropriate adjuvant treatment and family genetic counseling. The authors did not advocate the use of radiotherapy as an adjuvant treatment in desmoplastic MB diagnosed in children younger than 5 years of age. They suggested that the desmoplastic subtype of MB in children younger than 2 years of age is a major diagnostic criterion for the diagnosis of NBCCS. Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11537

Entities:  

Mesh:

Year:  2003        PMID: 12879481     DOI: 10.1002/cncr.11537

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

1.  Correlation between imaging features and epithelial cell proliferation in keratocystic odontogenic tumour.

Authors:  K Ba; X Li; H Wang; Y Liu; G Zheng; Z Yang; M Li; K Shimizutani; T Koseki
Journal:  Dentomaxillofac Radiol       Date:  2010-09       Impact factor: 2.419

2.  Gorlin syndrome and bilateral ovarian fibroma.

Authors:  Fernanda Pirschner; Pollyana Marçal Bastos; George Luiz Contarato; Anna Carolina Bon Lima Bimbato; Antônio Chambô Filho
Journal:  Int J Surg Case Rep       Date:  2012-06-02

3.  Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma.

Authors:  Ingrid Slade; Anne Murray; Sandra Hanks; Ajith Kumar; Lisa Walker; Darren Hargrave; Jenny Douglas; Charles Stiller; Louise Izatt; Nazneen Rahman
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

Review 4.  Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.

Authors:  D G R Evans; J M Birch; R T Ramsden; S Sharif; M E Baser
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

5.  Radiation-induced brain tumours in nevoid basal cell carcinoma syndrome: implications for treatment and surveillance.

Authors:  Q Choudry; H C Patel; N T Gurusinghe; D G Evans
Journal:  Childs Nerv Syst       Date:  2006-09-15       Impact factor: 1.475

6.  Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.

Authors:  Léa Guerrini-Rousseau; Christelle Dufour; Pascale Varlet; Julien Masliah-Planchon; Franck Bourdeaut; Marine Guillaud-Bataille; Rachid Abbas; Anne-Isabelle Bertozzi; Fanny Fouyssac; Sophie Huybrechts; Stéphanie Puget; Brigitte Bressac-De Paillerets; Olivier Caron; Nicolas Sevenet; Marina Dimaria; Sophie Villebasse; Olivier Delattre; Dominique Valteau-Couanet; Jacques Grill; Laurence Brugières
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

Review 7.  [Hereditary tumor syndromes in neuropathology].

Authors:  C Mawrin
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

8.  Deficient expression of aldehyde dehydrogenase 1A1 is consistent with increased sensitivity of Gorlin syndrome patients to radiation carcinogenesis.

Authors:  Aaron T Wright; Thierry Magnaldo; Ryan L Sontag; Lindsey N Anderson; Natalie C Sadler; Paul D Piehowski; Yannick Gache; Thomas J Weber
Journal:  Mol Carcinog       Date:  2013-11-27       Impact factor: 4.784

9.  Keratocystic odontogenic tumors related to Gorlin-Goltz syndrome: A clinicopathological study.

Authors:  Mohammed Israr Ul Khaliq; Ajaz A Shah; Irshad Ahmad; Shahid Hasan; Sagar S Jangam
Journal:  J Oral Biol Craniofac Res       Date:  2015-11-11

Review 10.  Nevoid basal cell carcinoma syndrome (Gorlin syndrome).

Authors:  Lorenzo Lo Muzio
Journal:  Orphanet J Rare Dis       Date:  2008-11-25       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.